id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1998-N-0051-0010,FDA,FDA-1998-N-0051,Over-the-Counter Human Drugs; Labeling Requirements; Delay of Implementation Date,Rule,Final Rule,2004-09-07T04:00:00Z,2004,9,2004-09-03T04:00:00Z,2004-12-03T04:59:59Z,2016-08-25T01:01:10Z,,0,0,090000648056e93f
FDA-1998-N-0051-0011,FDA,FDA-1998-N-0051,Over-the-Counter Human Drugs; Labeling Requirements; Delay of Implementation,Rule,NFR-Notice of Final Rule,2004-09-07T04:00:00Z,2004,9,2004-09-03T04:00:00Z,2004-12-03T04:59:59Z,2009-04-22T03:55:30Z,,0,0,090000648056e940
FDA-1998-N-0051-0009,FDA,FDA-1998-N-0051,Over-the-Counter Human Drugs; Labeling Requirements; Delay of Implementation Date,Rule,Final Rule,2004-09-07T04:00:00Z,2004,9,2004-09-03T04:00:00Z,2004-12-03T04:59:59Z,2016-08-24T14:36:20Z,,0,0,090000648056e93e
FDA-1998-N-0051-0008,FDA,FDA-1998-N-0051,Letter from FDA CDER to HHS Supply Service Center,Other,Answer,2004-04-13T04:00:00Z,2004,4,,,2016-08-24T14:33:50Z,,0,0,090000648056e93d